Substance Use DisordersNCT05777200
Sociodemographic and Clinical Characteristics of Patients Admitted to the Addiction Management Unit
An observational study of Substance Use Disorders, run by Assiut University at 1 site in Egypt.
Trial summary
Substance use disorder (SUD) is a dynamic process that changes constantly over time with new trends of drug dependence emerge every now and then, thus timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Substance Use Disorders
- What is being tested?
- Supportive psychotherapy
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 106 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Apr 2024to 10 Nov 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with substance use disorder, based on DSM-5 criteria, who are admitted to the addiction management unit of Assiut University Hospital.
Who may be able to join
- All patients with substance use disorder who are admitted to the addiction treatment unit.
- Accept participating into the study.
Who cannot join
- Patients refuse participating in the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Sociodemographic and Clinical Characteristics of Patients Admitted to the Addiction Management Unit of Assiut University Hospital
Substance use disorder (SUD) is a dynamic process that changes constantly over time with new trends of drug dependence emerge every now and then, thus timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms.
Identifying personal, social, and demographic characteristics of patients with this disorder at the local, regional, and national levels helps physicians, health authorities, and policy-makers detect early emerging trends and enable them better plan and implement prevention, treatment, and rehabilitation programs.
This study aims to identify sociodemographic, personal characteristics, as well as patterns of illicit drug abuse in patients admitted for addiction treatment.
Read the detailed description
Substance use disorder (SUD) is a complex condition in which there is uncontrolled use of a substance despite its harmful consequences. People with SUD have an intense focus on using a certain substance(s) such as alcohol, tobacco, or illicit drugs, to the point where the person's ability to function in day-to-day life becomes impaired. People keep using the substance even when they know it is causing or will cause problems.
Drug use brings with it the likelihood of several negative health consequences. These can include a wide range of physical and mental health disorders, foremost of which are dependence, HIV infection, hepatitis-related liver diseases, overdose and premature death.
The problem of substance use is becoming one of the most serious and rapidly growing phenomena all over the world. It accounts for substantial global morbidity, mortality, and financial and social burden. According to Global Burden of Disease (GBD) study, there were an estimated 494,000 drug-related deaths attributable to the use of drugs in 2019.
In 2020, 1 in every 18 people aged 15-64 worldwide - an estimated 284 million people (5.6 per cent of the population) - had used a drug in the past 12 months. However, the coverage of interventions for the treatment of drug use disorders remains low overall. Implementation of scientific evidence-based drug prevention interventions remains low as well, especially in middle- and low-income countries.
In Egypt, SUD is a serious public health threat. Recent studies have demonstrated increases in the prevalence of the use of tobacco, illegal drugs, and over-the-counter drugs, particularly among youth.
Drug treatment registers are often used as a proxy indicator of treatment demand. This information is useful for analysis of service utilization and can be used as an indicator of trends in prevalence and patterns of high-risk drug consumption.
Assiut University Hospital is the biggest hospital in Upper Egypt, and it provides health services for Assiut city and most of the neighboring governorates. Addiction management unit of Assiut University Hospital contains 16 beds, based on paid service and about 400 patients have been admitted per year.
SUD is a dynamic process that changes constantly over time with new trends of drug dependence emerge every now and then, thus timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms.
Identifying personal, social, and demographic characteristics of patients with this disorder at the local, regional, and national levels helps physicians, health authorities, and policy-makers detect early emerging trends and enable them better plan and implement prevention, treatment, and rehabilitation programs.
This study aims to identify sociodemographic, personal characteristics, as well as patterns of illicit drug abuse in patients admitted for addiction treatment.
- Conditions
- Substance Use Disorders
- Being tested
- Supportive psychotherapy
- Keywords
- substance use disorder, addiction, Sociodemographic characteristics, personality traits, patterns of substance abuse
- Medical subject headings
- Substance-Related Disorders, Behavior, Addictive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Supportive psychotherapyBehavioural
Counselling patients, providing supportive psychotherapy to help them detox their illicit drug usage, and help them rehabilitate again into society.
What is being measured
The primary outcome is the main question the study is designed to answer.
To identify the sociodemographic characteristics of patients with substance use disorder attending addiction treatment unit.
- Sociodemographic characteristics with a special prepared survey that includes:
- Personal information, and socioeconomic status.(Age, gender, marital status, work, income, educational level, ...etc)
- Previous admissions/trials for detox.(number of previous admissions/trials detox, where they were, maximum abstinence time, and the withdrawal symptoms the patient had)
- Medical, psychological, social, financial, and legal aspects of addiction.
- Adverse life events dating before starting addiction.
- Detailed description of substance(s) used.( Substances used, doses, route of administration, when, where, and with whom he prefers taking the drug)
- Psychiatric interview.
Measured: One week
To identify personality traits of patients with substance use disorder attending addiction treatment unit.
Data about personality traits of patients with substance use disorder will be obtained through:
- Psychiatric interview.
- The Symptom Checklist-90-Revised (SCL-90-R).
- The Structured Interview for the Five-Factor Model of Personality (SIFFM).
- Addiction severity Index (ASI).
Measured: One week
To identify patterns of substance abuse among patients with substance use disorder attending addiction treatment unit.
Data about patterns of substance abuse will be gathered through:
- Psychiatric interview.
- Addiction Severity Index (ASI).
- Urine Drug Screen.
Measured: One week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Mar 2023
- Study start1 Apr 2024
- Primary completion31 Mar 2025
- Study completion10 Nov 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Substance Use DisordersStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 106 participants (actual)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mena Fahy Rizq Farag, Assiut University
- Investigators
- Alaa El Din M. Darweesh, Prof., Study chair, Department of Neurology and Psychiatry, Faculty of Medicine, Assiut UniversityRomany H. Gabra, Dr, Study director, Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05777200
- Sponsor's protocol ID
- Substance-use disorder
- Status last verified
- Jun 2025
- First submitted
- 27 Feb 2023
- Last updated
- 13 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Loffredo CA, Boulos DN, Saleh DA, Jillson IA, Garas M, Loza N, Samuel P, Shaker YE, Ostrowski MJ, Amr S. Substance use by Egyptian youth: current patterns and potential avenues for prevention. Subst Use Misuse. 2015 Apr;50(5):609-18. doi: 10.3109/10826084.2014.997391. Epub 2015 Jan 28.
PubMed 25629955Connery HS, McHugh RK, Reilly M, Shin S, Greenfield SF. Substance Use Disorders in Global Mental Health Delivery: Epidemiology, Treatment Gap, and Implementation of Evidence-Based Treatments. Harv Rev Psychiatry. 2020 Sep/Oct;28(5):316-327. doi: 10.1097/HRP.0000000000000271.
PubMed 32925514Darweesh, A. E., Agban, M., Mohammed, M. H., & Gabra, R. H. (2020). Association between opioid use disorder (tramadol) and serum level of interleukin-2. Middle East Current Psychiatry, 27(1). https://doi.org/10.1186/s43045-020-00037-w
Rabie, M., Shaker, N.M., Gaber, E. et al. Prevalence updates of substance use among Egyptian adolescents. Middle East Curr Psychiatry 27, 4 (2020). https://doi.org/10.1186/s43045-019-0013-8
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Sociodemographic and Clinical Characteristics of Patients Admitted to the Addiction Management Unit of Assiut University Hospital
- ClinicalTrials.gov ID
- NCT05777200
- Acronym / sponsor ID
- Substance-use disorder
- Conditions
- Substance Use Disorders
- Keywords
- substance use disorder, addiction, Sociodemographic characteristics, personality traits, patterns of substance abuse
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 106 participants (actual)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 Apr 2024 (actual)
- Primary completion
- 31 Mar 2025 (actual)
- Study completion
- 10 Nov 2025 (actual)
- First posted
- 21 Mar 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Substance use disorder (SUD) is a dynamic process that changes constantly over time with new trends of drug dependence emerge every now and then, thus timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms.
Identifying personal, social, and demographic characteristics of patients with this disorder at the local, regional, and national levels helps physicians, health authorities, and policy-makers detect early emerging trends and enable them better plan and implement prevention, treatment, and rehabilitation programs.
This study aims to identify sociodemographic, personal characteristics, as well as patterns of illicit drug abuse in patients admitted for addiction treatment.
Detailed description
Substance use disorder (SUD) is a complex condition in which there is uncontrolled use of a substance despite its harmful consequences. People with SUD have an intense focus on using a certain substance(s) such as alcohol, tobacco, or illicit drugs, to the point where the person's ability to function in day-to-day life becomes impaired. People keep using the substance even when they know it is causing or will cause problems.
Drug use brings with it the likelihood of several negative health consequences. These can include a wide range of physical and mental health disorders, foremost of which are dependence, HIV infection, hepatitis-related liver diseases, overdose and premature death.
The problem of substance use is becoming one of the most serious and rapidly growing phenomena all over the world. It accounts for substantial global morbidity, mortality, and financial and social burden. According to Global Burden of Disease (GBD) study, there were an estimated 494,000 drug-related deaths attributable to the use of drugs in 2019.
In 2020, 1 in every 18 people aged 15-64 worldwide - an estimated 284 million people (5.6 per cent of the population) - had used a drug in the past 12 months. However, the coverage of interventions for the treatment of drug use disorders remains low overall. Implementation of scientific evidence-based drug prevention interventions remains low as well, especially in middle- and low-income countries.
In Egypt, SUD is a serious public health threat. Recent studies have demonstrated increases in the prevalence of the use of tobacco, illegal drugs, and over-the-counter drugs, particularly among youth.
Drug treatment registers are often used as a proxy indicator of treatment demand. This information is useful for analysis of service utilization and can be used as an indicator of trends in prevalence and patterns of high-risk drug consumption.
Assiut University Hospital is the biggest hospital in Upper Egypt, and it provides health services for Assiut city and most of the neighboring governorates. Addiction management unit of Assiut University Hospital contains 16 beds, based on paid service and about 400 patients have been admitted per year.
SUD is a dynamic process that changes constantly over time with new trends of drug dependence emerge every now and then, thus timely information about trends in psychoactive substance use could yield tailored interventions and reduce potential harms.
Identifying personal, social, and demographic characteristics of patients with this disorder at the local, regional, and national levels helps physicians, health authorities, and policy-makers detect early emerging trends and enable them better plan and implement prevention, treatment, and rehabilitation programs.
This study aims to identify sociodemographic, personal characteristics, as well as patterns of illicit drug abuse in patients admitted for addiction treatment.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with substance use disorder, based on DSM-5 criteria, who are admitted to the addiction management unit of Assiut University Hospital.
Key inclusion criteria (2 listed)
- All patients with substance use disorder who are admitted to the addiction treatment unit.
- Accept participating into the study.
Key exclusion criteria (1 listed)
- Patients refuse participating in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Supportive psychotherapyCounselling patients, providing supportive psychotherapy to help them detox their illicit drug usage, and help them rehabilitate again into society. | Behavioural | – |
Primary outcome
To identify the sociodemographic characteristics of patients with substance use disorder attending addiction treatment unit.
Time frame: One week
1. Sociodemographic characteristics with a special prepared survey that includes: * Personal information, and socioeconomic status.(Age, gender, marital status, work, income, educational level, ...etc) * Previous admissions/trials for detox.(number of previous admissions/trials detox, where they were, maximum abstinence time, and the withdrawal symptoms the patient had) * Medical, psychological, social, financial, and legal aspects of addiction. * Adverse life events dating before starting addiction. * Detailed description of substance(s) used.( Substances used, doses, route of administration, when, where, and with whom he prefers taking the drug) 2. Psychiatric interview.
To identify personality traits of patients with substance use disorder attending addiction treatment unit.
Time frame: One week
Data about personality traits of patients with substance use disorder will be obtained through: 1. Psychiatric interview. 2. The Symptom Checklist-90-Revised (SCL-90-R). 3. The Structured Interview for the Five-Factor Model of Personality (SIFFM). 4. Addiction severity Index (ASI).
To identify patterns of substance abuse among patients with substance use disorder attending addiction treatment unit.
Time frame: One week
Data about patterns of substance abuse will be gathered through: 1. Psychiatric interview. 2. Addiction Severity Index (ASI). 3. Urine Drug Screen.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2026.
- Background: PubMed 25629955Loffredo CA, Boulos DN, Saleh DA, Jillson IA, Garas M, Loza N, Samuel P, Shaker YE, Ostrowski MJ, Amr S. Substance use by Egyptian youth: current patterns and potential avenues for prevention. Subst Use Misuse. 2015 Apr;50(5):609-18. doi: 10.3109/10826084.2014.997391. Epub 2015 Jan 28.
- Background: PubMed 32925514Connery HS, McHugh RK, Reilly M, Shin S, Greenfield SF. Substance Use Disorders in Global Mental Health Delivery: Epidemiology, Treatment Gap, and Implementation of Evidence-Based Treatments. Harv Rev Psychiatry. 2020 Sep/Oct;28(5):316-327. doi: 10.1097/HRP.0000000000000271.
- BackgroundDarweesh, A. E., Agban, M., Mohammed, M. H., & Gabra, R. H. (2020). Association between opioid use disorder (tramadol) and serum level of interleukin-2. Middle East Current Psychiatry, 27(1). https://doi.org/10.1186/s43045-020-00037-w
- BackgroundRabie, M., Shaker, N.M., Gaber, E. et al. Prevalence updates of substance use among Egyptian adolescents. Middle East Curr Psychiatry 27, 4 (2020). https://doi.org/10.1186/s43045-019-0013-8
- Global Burden of Disease (2019) study. (n.d.). GBD results. Institute for Health Metrics and Evaluation. Retrieved September 23, 2022Link provided by the sponsor.
- American Psychiatric Association. (n.d.). What is a substance use disorder? Psychiatry.org - What Is a Substance Use Disorder? Retrieved September 23, 2022Link provided by the sponsor.
Related trials for Substance Use Disorders
Not yet recruiting
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Enrolling by invitationObservational study
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
Substance Use Disorders (SUDs)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Not yet recruiting
Substance Use and Media Preferences
Substance Use Behavior, Cannabis Intoxication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alaa El Din M. Darweesh, Prof. study chair
Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University
Romany H. Gabra, Dr study director
Department of Neurology and Psychiatry, Faculty of Medicine, Assiut University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Substance Use Disorders, run by Assiut University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To identify the sociodemographic characteristics of patients with substance use disorder attending addiction treatment unit. (time frame: One week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05777200, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.